2007Zhongguo linchuang yaolixue yu zhiliaoxueRequires access

Effect of matrine on U937 cells and human umbilical vein endothelial cells proliferation

Zong-Gan Huang

Open publisher page 0 citations

Abstract

AIM:To observe the proliferative effects of matrine on U937 cells and human umbilical vein endothelial cells. METHODS: The effects of matrine on U937 cells and human umbilical vein endothelial cells proliferation were observed by morphology, MTT and cell cycle detection. RESULTS: U937 cells treated with matrine at the concentration of 0.2 mg/mL to 0.5 mg/mL for 24 h were inhibited proliferation in a time and dose-dependent manner detected by MTT (P0.05 or P0.01) and increased at the S stage (P0.05 or P0.01). The half-inhibition concentration (IC50) was 0.4 mg/mL in U937 cells compared with human umbilical vein endothelial cells (P0.05). HUVECs treated with matrine at the concentration of 0.1 to 0.5 mg/mL for 48 h showed no effect on cell cycle (P0.05). CONCLUSION: Matrine has an inhibited effect on U937 cells proliferation in a time and dose-dependent manner.

About this research paper

What this paper is about

AIM:To observe the proliferative effects of matrine on U937 cells and human umbilical vein endothelial cells. METHODS: The effects of matrine on U937 cells and human umbilical vein endothelial cells proliferation were observed by morphology, MTT and cell cycle detection. RESULTS: U937 cells treated with matrine at the concentration of 0.2 mg/mL to 0.5 mg/mL for 24 h were inhibited proliferation in a time and dose-dependent manner detected by MTT (P0.05 or P0.01) and increased at the S stage (P0.05 or P0.01). The half-inhibition concentration (IC50) was 0.4 mg/mL in U937 cells compared with human umbilical vein endothelial cells (P0.05). HUVECs treated with matrine at the concentration of 0.1 to 0.5 mg/mL for 48 h showed no effect on cell cycle (P0.05). CONCLUSION: Matrine has an inhibited effect on U937 cells proliferation in a time and dose-dependent manner.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

AIM:To observe the proliferative effects of matrine on U937 cells and human umbilical vein endothelial cells. METHODS: The effects of matrine on U937 cells and human umbilical vein endothelial cells proliferation were observed by morphology, MTT and cell cycle detection. RESULTS: U937 cells treated with matrine at the concentration of 0.2 mg/mL to 0.5 mg/mL for 24 h were inhibited proliferation in a time and dose-dependent manner detected by MTT (P0.05 or P0.01) and increased at the S stage (P0.05 or P0.01). The half-inhibition concentration (IC50) was 0.4 mg/mL in U937 cells compared with human umbilical vein endothelial cells (P0.05). HUVECs treated with matrine at the concentration of 0.1 to 0.5 mg/mL for 48 h showed no effect on cell cycle (P0.05). CONCLUSION: Matrine has an inhibited effect on U937 cells proliferation in a time and dose-dependent manner.

Key concepts: Matrine, Umbilical vein, U937 cell, MTT assay, IC50, Chemistry, Cell growth, Human umbilical vein endothelial cell

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of matrine on U937 cells and human umbilical vein endothelial cells proliferation — Research Paper | ScholarLens